Dermira, INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$1.8Mgeneral payments (2019-2025)
$3,193research payments (2019-2025)
6,094clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $1.4M
2020 $325K
2021 $59K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Specialties it works with most

Dermatology $1.3M
Pediatric Dermatology $95K
Mohs-Micrographic Surgery $83K
Procedural Dermatology $78K
Internal Medicine $31K
Pediatrics $27K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
David Cohen New York, NY Dermatology $118,601.76
Adam Friedman Washington, DC Dermatology $49,880.59
Edward Lain Austin, TX Dermatology $43,775.53
Jared Jagdeo Brooklyn, NY Procedural Dermatology $39,889.89
Lawrence Eichenfield San Diego, CA Pediatric Dermatology $39,430.54
Seemal Desai Plano, TX Dermatology $39,160.05
Jonathan Silverberg Washington, DC Dermatology $39,097.36
David Kaplan Overland Park, KS Dermatology $38,038.35
James Del Rosso Las Vegas, NV Mohs-Micrographic Surgery $37,047.24
Dee Glaser Saint Louis, MO Dermatology $35,897.27

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.